These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9455703)

  • 1. Neutralizing IGF-1 monoclonal antibody with cross-species reactivity.
    Su JL; Stimpson S; Edwards C; Van Arnold J; Burgess S; Lin P
    Hybridoma; 1997 Dec; 16(6):513-8. PubMed ID: 9455703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
    Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts.
    Cara JF; Stuart CA; Furlanetto RW
    Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.
    Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE
    J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I.
    Cascieri MA; Bayne ML; Ber E; Green BG; Men GW; Chicchi GG
    Endocrinology; 1990 Jun; 126(6):2773-7. PubMed ID: 1693561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.
    Soos MA; Field CE; Lammers R; Ullrich A; Zhang B; Roth RA; Andersen AS; Kjeldsen T; Siddle K
    J Biol Chem; 1992 Jun; 267(18):12955-63. PubMed ID: 1377676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model.
    Thompson MA; Cox AJ; Whitehead RH; Jonas HA
    Endocrinology; 1990 Jun; 126(6):3033-42. PubMed ID: 1693565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor stimulates DNA synthesis in cells overexpressing the insulin-like growth factor-I receptor.
    Yoshinouchi M; Miura M; Gaozza E; Li SW; Baserga R
    Mol Endocrinol; 1993 Sep; 7(9):1161-8. PubMed ID: 8247018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.
    Maloney EK; McLaughlin JL; Dagdigian NE; Garrett LM; Connors KM; Zhou XM; Blättler WA; Chittenden T; Singh R
    Cancer Res; 2003 Aug; 63(16):5073-83. PubMed ID: 12941837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor.
    Morrell DJ; Dadi H; More J; Taylor AM; Dabestani A; Buchanan CR; Holder AT; Preece MA
    J Mol Endocrinol; 1989 May; 2(3):201-6. PubMed ID: 2751828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for species and ligand specificity of a monoclonal antibody raised against human IGF-I.
    Van Wyk JJ; Bruton ET
    Endocrinology; 1997 Oct; 138(10):4521-2. PubMed ID: 9322977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of radioimmunoassay for measurement of insulin-like growth factor-I (IGF-I) by using anti-IGF-I monoclonal antibody.
    Tominaga M; Tominaga K; Kinoshita Y; Terano Y; Yamamoto K
    Cell Mol Biol (Noisy-le-grand); 1995 Jun; 41(4):505-14. PubMed ID: 7549787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.
    Goetsch L; Gonzalez A; Leger O; Beck A; Pauwels PJ; Haeuw JF; Corvaia N
    Int J Cancer; 2005 Jan; 113(2):316-28. PubMed ID: 15386423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
    Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
    Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
    Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R
    Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.
    Minuto F; Del Monte P; Barreca A; Alama A; Cariola G; Giordano G
    Cancer Res; 1988 Jul; 48(13):3716-9. PubMed ID: 3378214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.